Pond Technologies


UiPath Integrates with Microsoft Copilot for Microsoft 365

UiPath exhibiting at booth FP46 at Microsoft Build conference to showcase how customers can boost employee productivity by leveraging UiPath Intelligent Document Processing and other UiPath Platform features directly from Microsoft Copilot for Microsoft 365 and Teams NEW YORK / May 21, 2024 / Business Wire / UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced an... Read more

Planet Labs and BASF Digital Farming Expand Strategic Partnership to Enhance Smart Farming Solutions From Space

SAN FRANCISCO / May 21, 2024 / Business Wire / Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights about Earth, today announced it has expanded its existing commercial partnership with BASF Digital Farming GmbH. Through this strategic partnership, BASF Digital Farming is growing its use of Planet satellite data products to power its advanced digital farming products and services from its xarvio®... Read more

Redwire Selected Among Leading Space Companies to Conduct Mars Surface-Imaging Study For NASA

JACKSONVILLE, Fla. / May 21, 2024 / Business Wire / Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that it has been awarded a NASA/JPL contract to conduct a study to conceptualize a Redwire-led commercial Mars spacecraft, which will utilize Redwire’s heritage spacecraft technology to provide surface imagery to industry and government customers.... Read more

Inseego Announces Industry’s First FIPS 140-2 Certified 5G Mobile Hotspot, MiFi® X PRO

Now available for sale through N. American mobile network operators and resellers SAN DIEGO / May 21, 2024 / Business Wire / Inseego Corp. (Nasdaq: INSG), a leader in 5G edge cloud solutions, announced the industry’s first FIPS 140-2 (Federal Information Processing Standard Publication 140-2) certified 5G mobile hotspot. MiFi® X PRO 5G mobile hotspot provides government agencies and businesses unparalleled... Read more

Tenet Fintech and Able View Global Sign Agreement in Principle for Distribution of Canadian Brands in China

Toronto, Ontario and Shanghai, China--(Newsfile Corp. - May 21, 2024) - Tenet Fintech Group Inc. (CSE: PKK) (OTC Pink: PKKFF) ("Tenet"), an innovative analytics service provider, owner and operator of the Cubeler® Business Hub, and Able View Global Inc. (NASDAQ: ABLV) ("Able View"), China's second largest international beauty and personal care brand manager, today announced that they have signed an agreement in... Read more

Elektros Discusses Cutting-Edge Charging Features, Potential African Lithium LOI, and a Solid Cap Structure Free of Debt and Convertible Securities

Sunny Isles Beach, Florida--(Newsfile Corp. - May 21, 2024) - Elektros (OTC Pink: ELEK) ("Elektros" or "the Company"), an emerging leader in the electric mobility industry, announced today it has made tremendous progress on its Multi-Port Charging Assembly and lithium mining capabilities in West Africa, a region ripe with potential business opportunities. Elektros's Multiplug charger represents a paradigm shift... Read more

Crown Fiber Optics Announces New Long-Haul Dark Fiber Construction From Las Cruces, New Mexico to El Paso, Texas

LOS ANGELES, CA / ACCESSWIRE / May 21, 2024 / Crown Electrokinetics Corp. (NASDAQ:CRKN) ("Crown" or the "Company"), a leading smart glass technology company and an expert in constructing fiber optic networks, today announced that it has secured a new long haul dark fiber construction project spanning approximately 250 miles from Las Cruces, New Mexico to El Paso, Texas. Corey Boaz, President of Construction for... Read more

Massimo Group Announces Expansion of its Manufacturing Facility in Garland, Texas

90,000 sq. ft. Warehouse Facility Expansion to Support Rapid Growth of Motor and Marine Product Verticals GARLAND, Texas, May 21, 2024 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO) ("Massimo"), a manufacturer and distributor of powersports vehicles and pontoon boats, today announced an expansion of its manufacturing facility in Garland, Texas, to support increased production across its motor and marine product... Read more

Exscientia Business Update for First Quarter 2024

Positive early Phase 1 results for BMS-partnered programme ‘4318 (PKC-theta inhibitor) GTAEXS617 (CDK7 inhibitor) initial Phase I data expected in 2H24 LSD1 and MALT1 inhibitor programmes expected to advance into clinic in 2H24 and early 2025, respectively AI-design integration enhanced with full experiment automation driving towards maximum speed, quality and autonomous drug design Leveraging technology... Read more

Banxa Reports Record Profitable March Quarter and Updates Guidance

TORONTO, May 21, 2024 /CNW/ - Banxa Holdings Inc. (TSXV: BNXA) (OTCQX: BNXAF) (FSE: AC00) ("Banxa'' or the "Company") is pleased to report the third quarter fiscal year 2024 ended March 31st, 2024 ("Q3") unaudited financial results and provides updated FY24 financial guidance. The full results including Management Discussion & Analysis ("MD&A") are available on SEDAR. Q3 FINANCIAL... Read more

Ault Alliance Achieves Profitability in the First Quarter of 2024; Revenue Increases by 55% to $45 Million

LAS VEGAS / May 21, 2024 / Business Wire / Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company (“Ault Alliance,” or the “Company”), reported its financial results for the first quarter ended March 31, 2024, which were disclosed on a quarterly report on Form 10-Q filed yesterday with the Securities and Exchange Commission. First quarter 2024 highlights include: Total revenue increased 55% to... Read more

Bionano Genomics Announces Three Publications Demonstrating OGM’s Utility for Cell and Gene Therapy

Three peer-reviewed publications collectively illustrate the building support for optical genome mapping (OGM) as a tool for cell and gene therapy development that allows researchers in academic medical centers and biopharmaceutical companies to assess genome integrity in therapeutic cell lines like chimeric antigen receptor-modified T cells (CAR-T), stem cells, and cell lines used for translational research in... Read more

Lexaria Biosciences Receives Two New Medical-Treatment Patents in Hypertension and Epilepsy

KELOWNA, BC / ACCESSWIRE / May 21, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces two important new patent awards. The Company has received a new granted patent in Lexaria's patent family #21: Compositions and Methods for Treating Hypertension. This is the Company's third granted US patent in this patent family. As... Read more

Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse Models

ta presented at Digestive Disease Week (DDW) 2024 Preclinical data demonstrate PALI-2108 to be safe, effective, and well tolerated PALI-2108 is orally delivered and colon-specific allowing for local activity with low systemic exposure PALI-2108 exhibited a dose-dependent efficacy response in two DSS colitis mouse models, achieving efficacy comparable to doses of apremilast considered intolerable for human use... Read more

Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya™ for the Management of Fibromyalgia

Tonmya is a potential new first-line, centrally acting non-opioid analgesic for the management of fibromyalgia, supported by statistically significant results from two Phase 3 trials Primary physician research found high level of interest in Tonmya as a potential new treatment option for fibromyalgia Significant dissatisfaction reported with drugs currently approved by FDA for the treatment of... Read more

Publication of Results of Pre-Clinical Studies Support Efficacy and Drug Delivery Mechanism Potential of RenovoRx’s TAMP™ Therapy Platform to Improve Targeted...

Data shows that the Trans-Arterial Micro-Perfusion (TAMP) platform increases intra-arterial pressure, improving drug delivery with 100-fold increase local tissue concentration of the therapy TAMP offers the potential to increase efficacy, improve safety and widen therapeutic window of drugs or other agents LOS ALTOS, Calif. / May 21, 2024 / Business Wire / RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq:... Read more

Sunshine Biopharma Reports 2024 First Quarter Results: Revenues Up 54%

NEW YORK, NY / ACCESSWIRE / May 21, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its 2024 first quarter report with the Securities and Exchange Commission. The Company reported gross revenues of $7,541,046 for the quarter... Read more

LAVA Therapeutics Provides Business Updates and Reports First Quarter 2024 Financial Results

LAVA-1207 dose escalation progressing in Phase 1/2a trial in prostate cancer, with pembrolizumab combination expected to begin in Q2 2024 Received $7.0 million clinical development milestone from Pfizer for PF-08046052 (formerly LAVA-1223) in Phase 1 LAVA-1266 on track for Q2 2024 IND submission Strong balance sheet with cash of $94.6 million supports runway into 2026 UTRECHT, The Netherlands and... Read more

XPENG launches industry's first AI-powered in-car OS, promoting AI-enabled smart driving experience

XPENG upgrades XOS 5.1.0, AI Tianji, the industry's first AI-powered in-car OS, for all eligible users on May 20 XOS 5.1.0 integrates end-to-end large model technology, enhancing the smart driving experience for XPENG car owners Intelligent and personalized in-car AI assistant services through AI assistant Xiao P, AI Chauffeur, and AI Bodyguard XPENG AI Valet Driver offers customizable, end-to-end smart... Read more

Generac Power Systems: Mean Green Introduces the World's Largest Electric Zero-Turn Mower

All-new EVO 96 wide-area electric mower is ideal for expansive properties. WAUKESHA, Wis., May 20, 2024 /PRNewswire/ -- Mean Green, a leading battery-powered, commercial-grade turf care manufacturer and a Generac Power Systems (NYSE: GNRC) company, today announced the expansion of its commercial-grade electric mower lineup with its all-new EVO 96, the world's largest electric zero-turn mower. With an... Read more

Ameresco Awarded $21 Million Contract to Illuminate Henderson's Streets with State-of-the-Art LED Technology

City of Henderson Partners with Ameresco for Streetlight Conversion Design-Build Project FRAMINGHAM, Mass. & HENDERSON, Nev. / May 20, 2024 / Business Wire / Ameresco, Inc., (NYSE: AMRC), a leading cleantech integrator specializing in energy efficiency and renewable energy, today announced its collaboration with the City of Henderson to upgrade street lighting infrastructure with state-of-the-art LED... Read more

ZEP-RE Extends Planet Labs Partnership for Drought Insurance Program in Horn of Africa

SAN FRANCISCO / May 20, 2024 / Business Wire / Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights about Earth, today announced a contract extension with ZEP-RE, an African reinsurance company headquartered in Nairobi, Kenya. The extension follows a successful first year of collaboration leveraging Planet’s insurance solutions to enhance drought risk protection in the Horn of Africa (HOA) and... Read more

Rekor Systems And MS2 Join Forces To Accelerate State DOT Transition To Digital Infrastructure And AI-Based Roadway Intelligence

MS2 - National Leader in Transportation Data Management Systems - Joins Rekor Partner Network COLUMBIA, MD / ACCESSWIRE / May 20, 2024 / Rekor Systems, Inc. (NASDAQ:REKR) ("Rekor" or the "Company"), a leader in developing and implementing state-of-the-art roadway intelligence technology, today announced a partnership with MS2, the national leader in Transportation Data Management Systems (TDMS). This... Read more

Steakholder Foods and The Industrial Technology Research Institute Announce Strategic Partnership to Bring the Company's Innovative Food Solutions to Taiwanese Market...

Partnership to Revolutionize Taiwanese Cuisine by Bringing the Company's 3D Printing Technology for Sustainable, Locally-Sourced Meat Alternatives REHOVOT, Israel, May 20, 2024 /PRNewswire/ -- Steakholder Foods Ltd. (Nasdaq: STKH), a leading innovator in alternative proteins and 3D printing technologies, announced a partnership agreement with the Industrial Technology Research Institute (ITRI), a Taiwan-based... Read more

Niu Technologies Announces Unaudited First Quarter 2024 Financial Results

BEIJING, May 20, 2024 (GLOBE NEWSWIRE) -- Niu Technologies (“NIU”, or “the Company”) (NASDAQ: NIU), the world’s leading provider of smart urban mobility solutions, today announced its unaudited financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Highlights Revenues were RMB 504.7 million, an increase of 21.0% year-over-year Gross margin was 18.9%, compared with 21.7% in... Read more

Sidus Space Reports First Quarter 2024 Financial Results and Provides Business Update

CAPE CANAVERAL, Fla. / May 20, 2024 / Business Wire / Sidus Space, Inc. (NASDAQ:SIDU) (the “Company” or “Sidus”), a Space and Data-as-a-Service satellite company, announced its financial results for the first quarter ended March 31, 2024 and provided a business update. The Company is scheduled to host a conference call and webcast today, Monday, May 20th, at 5:00 p.m. ET. “During the first quarter of 2024, we... Read more

Mawson Infrastructure Announces Monthly Operational Update for April 2024

Total Overall Revenue up 65% Y/Y from April last year Self-Mining Business Revenue up 73% Y/Y from April last year Co-Location Business Revenue up 105% Y/Y from April last year Announced 20 MW Expansion Plan increasing total capacity to 129 MW MIDLAND, Pa., May 20, 2024 (GLOBE NEWSWIRE) -- Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or “the Company”), a digital infrastructure company,... Read more

Regeneron Pharmaceuticals: Dupixent® (dupilumab) Late-Breaking Data from NOTUS Confirmatory Phase 3 COPD Trial Presented at ATS and Published in The New England...

NOTUS results confirm landmark data from the Phase 3 BOREAS trial and show Dupixent significantly reduced exacerbations by 34% and improved lung function, compared to placebo, in uncontrolled chronic obstructive pulmonary disease (COPD) with evidence of type 2 inflammation Data support the potential of Dupixent as the first new treatment approach in more than a decade and first-ever targeted therapy for... Read more

Esperion Therapeutics: Bempedoic Acid Met Primary Endpoint of Phase 3 Trial in Japan for the Treatment for Hypercholesterolemia

ANN ARBOR, Mich., May 20, 2024 (GLOBE NEWSWIRE) -- Esperion (Nasdaq: ESPR) and Otsuka Pharmaceutical Co., Ltd (Otsuka) announced today that the primary endpoint was achieved in the Phase 3 trial in Japan for bempedoic acid as a potential treatment for patients with hypercholesterolemia. The trial demonstrated statistically significant outcomes on the primary endpoint for bempedoic acid and highlighted its potential... Read more

eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as...

SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 20, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer, today announced a collaboration to conduct an investigator-sponsored trial (IST) evaluating zotatifin in combination with abemaciclib and letrozole in patients with estrogen... Read more

Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate

NORTHVALE, NJ / ACCESSWIRE / May 20, 2024 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that it received approval from the US Food and Drug Administration (FDA) for an Abbreviated New Drug Application (ANDA) for generic Methotrexate Sodium 2.5 mg tablets. Methotrexate belongs to a class of drugs known as... Read more

Lisata Therapeutics Receives Paediatric Investigation Plan Waiver from the European Medicines Agency for Certepetide in Pancreatic Cancer

Waiver confirms that paediatric studies of certepetide in pancreatic cancer are not needed Significant clinical trial burden and costs avoided due to waiver BASKING RIDGE, N.J., May 20, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other... Read more

Ensysce Biosciences Continues Collaboration to Advance the Clinical Development of Innovative Overdose Protection Platform

New Study to Confirm Overdose Protection Across Full Dosage Range of Breakthrough Therapy Opioid PF614-MPAR SAN DIEGO, CA / ACCESSWIRE / May 20, 2024 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced the renewal of its... Read more

Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale

New production process will be developed based on Pluri’s proprietary 3D cell expansion technology Human breast milk oligosaccharides are known to shape the gut microbiota and thus provide health benefits to adults Global elderly nutrition market is valued at $25.2 billion, estimated to reach $39.7 billion in less than 10 years HAIFA, Israel, May 20, 2024 (GLOBE NEWSWIRE) -- Leading biotechnology company... Read more

Healthy Extracts Reports First Quarter 2024 Financial Results

Net Revenue up 12% with Strong Subscription-Based Revenue Growth LAS VEGAS, NV / ACCESSWIRE / May 20, 2024 / Healthy Extracts Inc. (OTCQB:HYEX), a platform for acquiring, developing, patenting, marketing, and distributing plant-based nutraceuticals that target select high-growth categories within the multibillion-dollar nutraceuticals market, reported results for the quarter ended March 31, 2024. All... Read more

Nextech3D.AI Announces New Deals and Renewals in 3D Modeling Business

Nextech3D.ai Continues to Sign New & Renewal 3D Modeling Deals plus AR Visualization For Enterprise Ecommerce TORONTO, ON / ACCESSWIRE / May 17, 2024 / Nextech3D.AI (OTCQX:NEXCF) (CSE:NTAR) (FSE:EP2), a patented 2D-3D generative AI-powered 3D model supplier (Patent #11,948,248) for major e-commerce retailers including Amazon, Miele, P&G, and Kohl's, is pleased to announce a series of exciting new deals... Read more

Titan Medical Provides Update on Planned Merger with Conavi

TORONTO, Ontario, May 17, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is providing an update on its planned merger with Conavi Medical Inc. (“Conavi”) pursuant to the definitive amalgamation agreement (the “Amalgamation Agreement”) dated March 17, 2024 (the “Transaction”), as previously announced on March 18, 2024 and April 22, 2024. Titan and Conavi are both working on satisfying... Read more

Ault Alliance’s Subsidiary, Sentinum, Announces 89 Bitcoin Mined in April 2024

LAS VEGAS / May 17, 2024 / Business Wire / Ault Alliance, Inc. (NYSE American: AULT), a diversified holding company (“Ault Alliance,” or the “Company”), announced today that its wholly owned subsidiary, Sentinum, Inc. (“Sentinum”) mined approximately 89 Bitcoin in April 2024. Of this total, approximately 46 Bitcoin were mined at Sentinum’s data center in Michigan, with the remaining approximately 43 Bitcoin having... Read more

Dosing Begins in Lexaria Bioscience Comprehensive GLP-1 Animal Study

Study WEIGHT-A24-1 will evaluate DehydraTECH-processed pure semaglutide and liraglutide Will DehydraTECH processing result in higher brain absorption of GLP-1 drugs? KELOWNA, BC / ACCESSWIRE / May 17, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms announces that dosing has begun in the 12-week animal study WEIGHT-A24-1... Read more

Avenir Wellness Solutions Reports Fourth Quarter 2023 Results

New Initiatives Showing Encouraging Results SHERMAN OAKS, CA / ACCESSWIRE / May 17, 2024 / Avenir Wellness Solutions, Inc. (OTCQB:AVRW) ("Avenir" or the "Company"), a proprietary broad platform technology and wellness company, today announced results for the fourth fiscal quarter ended December 30, 2023. Key financial highlights for the fourth quarter included the following: Net revenue in the fourth quarter... Read more